Sientra logo
Sientra SIEN
report update icon

Quarterly report 2023-Q3
added 05-16-2026

Sientra Financial Statements 2022-2011 | SIEN

Annual Financial Statements Sientra

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

- 20.9 M 19.5 M 363 M 323 M 269 M 155 M 93.4 M 42.7 M - - -

Shares

7.18 M 5.71 M 5.02 M 40.7 M 25.4 M 19.2 M 18.2 M 15.8 M 2.55 M 233 K 276 K -

Historical Prices

- 3.67 3.89 8.94 12.7 14.1 8.52 5.92 16.8 - - -

Net Income

-22 M -16.1 M -89.9 M -107 M -82.6 M -64 M -40.2 M -41.2 M -5.81 M -19.1 M -23.4 M -

Revenue

25.1 M 22.6 M 55 M 46.4 M 68.1 M 36.5 M 20.7 M 38.1 M 44.7 M 35.2 M 10.4 M -

Cost of Revenue

49 M 36.3 M 23.6 M 16.4 M 26.8 M 14.2 M 6.88 M - - - - -

Gross Profit

3.23 M 12.3 M 31.4 M 30 M 41.3 M 22.4 M 13.9 M 27.5 M 33.2 M 26.6 M 8.1 M -

Operating Income

-69 M -46.4 M -47.4 M -54.9 M -79.8 M -62.9 M -40 M -38.5 M -5.78 M -18.2 M -23.4 M -

Interest Expense

9.11 M 8.25 M 9.44 M 4.57 M 3.43 M 1.23 M 98 K 3.1 M 2.17 M 872 K -1 K -

EBITDA

-62.4 M -42 M -44 M -53.2 M -76.5 M -59.9 M -38.9 M -38.2 M -5.51 M -17.9 M -23.1 M -

Operating Expenses

111 M 90.7 M 78.8 M 84.9 M 121 M 85.3 M 53.9 M 66 M 39 M 44.8 M 31.5 M -

General and Administrative Expenses

41.5 M 31.8 M 32.3 M 36.4 M 42.4 M 31.5 M 22 M 18.7 M 10.7 M 18.1 M 9.94 M -

All numbers in USD currency

Quarterly Income Statement Sientra

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

11.3 M 11.2 M 12.2 M 10.7 M 62.8 M 62.6 M 62.3 M 62.2 M 58 M 57.6 M 54.3 M 50.6 M 50.4 M 50.1 M 49.9 M 49.5 M 49.4 M 34.3 M 29.1 M 28.6 M 28.5 M 24.8 M 19.6 M 19.4 M 19.3 M 19.1 M 18.8 M 18.6 M 18.2 M 18.1 M 18.1 M 18 M 15.2 M 14.9 M 14.9 M 14.9 M 209 K 209 K 208 K 207 K 206 K - - - - - - - - - -

Net Income

-14.8 M -9.48 M -12.9 M - -15 M -18.3 M -18 M - 28.4 M -20.1 M -54.7 M -21.2 M -5.82 M -34.3 M -28.6 M -20.2 M -22.4 M -37.7 M -26.5 M -24.6 M -20.5 M -18 M -19.4 M -17.8 M -14.4 M -20.4 M -11.4 M -8.07 M -9.96 M -10.2 M -11.9 M -28.2 M -6.6 M -2.99 M -3.38 M -3.2 M -1.45 M -160 K -1 M -3.08 M -6.48 M -5.46 M -4.11 M - - - - - - - -

Revenue

19.5 M 23.1 M 22.6 M - 22.6 M 21.5 M 21.4 M - 19.6 M 20.1 M 23.2 M 22.6 M 19.2 M 12.4 M 16.9 M 23.2 M 22.4 M 20.5 M 17.6 M 19 M 16.9 M 17.6 M 14.7 M 11.1 M 9.82 M 8.17 M 7.49 M - 6.53 M - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

9.52 M 10.5 M 10.4 M - 9.79 M 8.77 M 8.55 M - 9.03 M 8.84 M 10.9 M - 8.39 M 5.55 M 6.79 M - 9.75 M 7.81 M 6.47 M - 6.4 M 6.66 M 6.1 M - 3.48 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

10 M 12.6 M 12.1 M - 12.8 M 12.7 M 12.8 M - 10.6 M 11.3 M 12.3 M 11.1 M 10.8 M 6.9 M 10.1 M 14.2 M 12.7 M 12.7 M 11.1 M 11.4 M 10.5 M 10.9 M 8.58 M 5.32 M 6.34 M 5.55 M 5.17 M 3.93 M 4.72 M 4.5 M 711 K 990 K 7 M 10.3 M 9.2 M 8.9 M 7.84 M 8.84 M 7.65 M 7.01 M 6.01 M 7.07 M 6.49 M - - - - - - - -

Operating Income

-9.4 M -7.11 M -10.6 M - -12.6 M -15.9 M -16.1 M - -11.7 M -9.16 M -9.82 M - -14 M -12.3 M -27 M - -21.5 M -37 M -25.9 M - -19.6 M -16.9 M -18.9 M - -13.9 M -20.2 M -11.4 M - -9.77 M -10.2 M -11.9 M - -5.57 M -2.12 M -2.63 M - -753 K -1.2 M -1.38 M - -6.23 M - - - - - - - - - -

Interest Expense

2.37 M 2.51 M 2.38 M - 2.36 M 2.32 M 1.9 M - 2.03 M 2.11 M 2 M - 2.06 M 3.61 M 1.62 M - 1.34 M 982 K 952 K - 953 K 867 K 655 K - 409 K 185 K 9 K - 105 K 12 K 1 K - 1.61 M 671 K 668 K - 665 K 411 K 431 K - 232 K - - - - - - - - - -

EBITDA

-3.85 M -3.43 M -8.72 M - -7.61 M -12.5 M -14.4 M - -8.54 M -7.05 M -8.44 M - -11 M -10.6 M -25.8 M - -18.9 M -35.2 M -25 M - -17.1 M -15.2 M -18 M - -11.8 M -19.1 M -10.8 M - -9.04 M -9.78 M -11.8 M - -5.34 M -1.97 M -2.55 M - -557 K -1.08 M -1.32 M - -6.02 M - - - - - - - - - -

Operating Expenses

19.4 M 19.7 M 22.7 M - 25.3 M 28.7 M 28.9 M - 22.3 M 20.4 M 22.1 M - 24.8 M 19.2 M 37.1 M - 34.1 M 49.7 M 36.9 M - 30 M 27.8 M 27.5 M - 20.2 M 25.8 M 16.6 M - 14.5 M 14.7 M 12.6 M - 12.6 M 12.4 M 11.8 M - 8.59 M 10 M 9.03 M - 12.2 M - - - - - - - - - -

General and Administrative Expenses

7.62 M 7.33 M 9.85 M - 9.32 M 12.1 M 10.2 M - 7.86 M 7.54 M 7.35 M - 10.2 M 7.96 M 9.3 M - 12.2 M 11.8 M 13.5 M - 11.9 M 10 M 9.5 M - 9.3 M 8.02 M 6.44 M - 7.3 M 5.36 M 5.29 M - 4.14 M 3.94 M 3.72 M - 2.63 M 2.64 M 2.27 M - 6.3 M - - - - - - - - - -

All numbers in USD currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements Sientra SIEN
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting Sientra plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Medical devices industry

Issuer Price % 24h Market Cap Country
AxoGen AxoGen
AXGN
$ 43.32 0.04 % $ 1.99 B usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 59.67 0.18 % $ 9.06 B usaUSA
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
$ 8.73 1.16 % $ 637 M israelIsrael
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 14.97 13.03 % $ 424 M usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 45.8 3.31 % $ 1.42 B usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 4.91 0.75 % $ 306 M usaUSA
Delcath Systems Delcath Systems
DCTH
$ 15.96 1.8 % $ 572 M usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 5.7 0.43 % $ 770 M usaUSA
Electromed Electromed
ELMD
$ 27.57 0.11 % $ 228 M usaUSA
Establishment Labs Holdings Establishment Labs Holdings
ESTA
$ 67.76 3.69 % $ 2.01 B costa-ricaCosta-rica
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
$ 86.82 0.51 % $ 50.8 B usaUSA
Align Technology Align Technology
ALGN
$ 148.17 4.36 % $ 10.7 B usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
$ 2.88 2.45 % $ 63.5 M usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
$ 15.53 2.76 % $ 1.19 B usaUSA
Inogen Inogen
INGN
$ 5.09 2.55 % $ 135 M usaUSA
Inspire Medical Systems Inspire Medical Systems
INSP
$ 69.06 0.57 % $ 2.03 B usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 0.63 0.08 % $ 10.7 M usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
$ 86.35 0.08 % $ 1.1 B usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
$ 126.32 0.02 % $ 4.39 B usaUSA
LENSAR LENSAR
LNSR
$ 7.15 0.14 % $ 85.5 M usaUSA
Medigus Ltd. Medigus Ltd.
MDGS
- 10.28 % $ 55.5 M israelIsrael
Apyx Medical Corporation Apyx Medical Corporation
APYX
$ 2.95 1.37 % $ 121 M usaUSA
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
Medtronic PLC Medtronic PLC
MDT
$ 89.3 0.08 % $ 114 B usaUSA
MiMedx Group MiMedx Group
MDXG
$ 4.77 0.2 % $ 705 M usaUSA
Accuray Incorporated Accuray Incorporated
ARAY
$ 0.23 1.0 % $ 28.2 M usaUSA
Myomo Myomo
MYO
$ 1.64 0.3 % $ 68.6 M usaUSA
Nano-X Imaging Ltd. Nano-X Imaging Ltd.
NNOX
$ 0.7 0.45 % $ 45.4 M israelIsrael
Nemaura Medical Nemaura Medical
NMRD
- -17.8 % $ 2.74 M britainBritain
InspireMD InspireMD
NSPR
$ 0.74 0.16 % $ 47.6 M israelIsrael
Orthofix Medical Orthofix Medical
OFIX
$ 9.18 2.23 % $ 364 M curacaoCuracao
Outset Medical Outset Medical
OM
$ 3.09 5.45 % $ 47 K usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
$ 44.62 0.31 % $ 66.1 B usaUSA
Insulet Corporation Insulet Corporation
PODD
$ 136.49 0.01 % $ 9.6 B usaUSA
Profound Medical Corp. Profound Medical Corp.
PROF
$ 5.74 0.16 % $ 174 M canadaCanada
Quanterix Corporation Quanterix Corporation
QTRX
$ 3.16 4.93 % $ 135 M usaUSA
AVITA Medical AVITA Medical
RCEL
$ 10.95 0.61 % $ 305 M australiaAustralia
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
Sintx Technologies Sintx Technologies
SINT
$ 1.78 3.98 % $ 4.94 M usaUSA
Smith & Nephew plc Smith & Nephew plc
SNN
$ 26.82 0.07 % $ 23.3 B britainBritain
Inari Medical Inari Medical
NARI
- - $ 4.23 B usaUSA
Sensus Healthcare Sensus Healthcare
SRTS
$ 3.03 0.32 % $ 49.5 M usaUSA
Stryker Corporation Stryker Corporation
SYK
$ 273.4 0.38 % $ 104 B usaUSA
Tactile Systems Technology Tactile Systems Technology
TCMD
$ 22.43 0.55 % $ 513 M usaUSA
TELA Bio TELA Bio
TELA
$ 1.3 0.71 % $ 61 M usaUSA
Viemed Healthcare Viemed Healthcare
VMD
$ 8.8 1.24 % $ 342 M usaUSA
Varex Imaging Corporation Varex Imaging Corporation
VREX
$ 18.45 0.05 % $ 764 M usaUSA